Biblio
Found 753 results
Filters: Spa is aggregate [Clear All Filters]
"Bcl-2 transduction protects human endothelial cell synthetic microvessel grafts from allogeneic T cells in vivo." J Immunol. 2004;173(5):3020-6.
"Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations." Blood. 2004;104(3):687-95.
"Evidence for a dual pathway of activation in CD43-stimulated Th2 cells: differential requirement for the Lck tyrosine kinase." Int Immunol. 2004;16(8):1215-23.
"Expression of epithelial cell iron-related genes upon infection by Neisseria meningitidis." Cell. Microbiol.. 2004;6(5):473-84.
"IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21." J. Immunol.. 2004;173(2):900-9.
"Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes." J Heart Lung Transplant. 2004;23(9):1077-81.
"Interferon alpha but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells." J Biol Chem. 2004;279(25):26789-96.
"Isoforms of the major peanut allergen Ara h 2: IgE binding in children with peanut allergy." Int Arch Allergy Immunol. 2004;135(2):101-7.
"Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors." J Immunol. 2004;173(11):6583-91.
"Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues." Int Immunol. 2004;16(9):1225-36.
"Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA." Transplantation. 2003;76(2):387-94.
"Engraftment of a vascularized human skin equivalent." FASEB J. 2003;17(15):2250-6.
"Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes." Biochem Biophys Res Commun. 2003;301(3):718-24.
"Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse." Springer Semin Immunopathol. 2003;25(2):167-80.
"In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen)." J. Immunol.. 2003;170(1):228-35.
"Pax5 is required for recombination of transcribed, acetylated, 5' IgH V gene segments." Genes Dev. 2003;17(1):37-42.
"Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis." J Immunol. 2003;171(7):3620-6.
"STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity." Proc Natl Acad Sci U S A. 2003;100(4):1879-84.
"Working with GFP in the brain." Biotechniques. 2003;34(3):492-4.
"Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response." J. Immunol.. 2002;168(3):1190-7.
"CTLA-4: new insights into its biological function and use in tumor immunotherapy." Nat. Immunol.. 2002;3(7):611-8.
"Cutting Edge: Internalization of transduced E-selectin by cultured human endothelial cells: comparison of dermal microvascular and umbilical vein cells and identification of a phosphoserine-type di-leucine motif." J Immunol. 2002;168(5):2091-5.
"DNA polymerase kappa deficiency does not affect somatic hypermutation in mice." Eur. J. Immunol.. 2002;32(11):3152-60.
"Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency." Proc. Natl. Acad. Sci. U.S.A.. 2002;99(25):16255-60.